$61.03+0.19 (+0.31%)
GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. in the Healthcare sector is trading at $61.03. The stock is currently near its 52-week low of $58.75, remaining 20.1% below its 200-day moving average. Technical signals show oversold RSI of 23 and bearish MACD signal, explaining why GEHC maintains its current current market pressure. The Whystock Score of 70/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internati...
The company's margins are coming under pressure in an inflationary environment.
GE HealthCare Technologies has already overhauled its operating structure and leadership, combining its Imaging and Advanced Visualization units into a US$14.60 billion Advanced Imaging Solutions segment and reporting first-quarter 2026 revenue of US$5,131 million alongside lower net income and reduced full-year profit guidance due to margin pressures and a supplier quality issue. At the same time, the company is pushing innovation with the Phase 2/3 LUMINA trial of its manganese-based MRI...
Why recent price weakness has investors rethinking GE HealthCare Technologies GE HealthCare Technologies has caught the eye of investors who are asking a simple question: is the recent share price around US$60.84 an opportunity or a warning sign about value? Over the short term, the stock has been under pressure, with returns of 12.9% over 7 days, 14.5% over 30 days, 26.5% year to date, and 9.9% over the past year. Recent coverage has focused on how this performance fits into the broader...
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks with highest upside potential. On April 29, GE HealthCare reported total revenues of $5.1 billion for Q1 2026, marking a 7.4% increase, with organic revenue growth contributing 2.9%. This growth was fueled by strong commercial performance in the Pharmaceutical Diagnostics/PDx, Imaging, […]
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best medical device stocks to invest in right now. Piper Sandler cut the price target on GE HealthCare Technologies Inc. (NASDAQ:GEHC) to $88 from $96 on April 17, reaffirming an Overweight rating on the shares. The firm stated that it is adding the recent acquisition of […]